drug development
Researchers gain better understanding of colon cancer that could help develop treatments
Researchers at the University of Luxembourg have discovered a molecular mechanism giving them a better understanding of how colon cancer develops and progresses, which could aid in the development of treatments to inhibit tumour growth. more
Partnership forms to enhance potential to identify hit drug candidates
Provider of label-free drug discovery solutions, SAMDI Tech, has joined forces with a provider of products and services that accelerate research and drug development efforts, Charles River Laboratories, to maximise its clients’ opportunities more
More disparity in KRAS mutations may mean varied drug development is needed, notes study
According to a new study, led by the University of Eastern Finland, there is much more variation in cancer-causing KRAS mutations than originally believed. more
Forendo Pharma raises additional funding to accelerate development of women’s health portfolio
Clinical stage drug development company, Forendo Pharma, has raised an additional €4 million of funding from Vesalius Biocapital III Partners, which will be used with other raised funds to accelerate the development of its women’s health portfolio. more
Innovations in drug development positively impact clinical trials and market launches
New innovations in drug development have a positive impact on clinical trial timelines, likelihood of market launch and inclusion on payer formularies, according to a new report released by the Economist Intelligence Unit and commissioned by PAREXEL more
Juniper Pharma Services expands UK manufacturing facilities
Contract development and manufacturing organisation (CDMO), Juniper Pharma Services, has revealed its expansion into its UK-based drug development and clinical trial manufacturing facilities. more
The landscape of outsourced work and how tech can help protect data
In this online exclusive, Brady Haggstrom, IDBS, looks at the changing landscape of drug development and delivery, which is more and more outsourced nowadays, and how technology can help protect sensitive research data. more
LabCorp acquires scientific process outsourcing company, Sciformix
Global life sciences company, LabCorp, has acquired scientific process outsourcing company, Sciformix — which will become a part of Covance, LabCorp’s drug development business. more
The top five tweets: From the visa cap to a research hub — what excited EPM readers this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more
The effect of new technologies on drug development
In this online exclusive, Graham Francis, product marketing manager at Kallik, explains how data integrity should be a top priority when using new technologies in the pharmaceutical industry. more
New big data rules threaten effective drug development
In this online exclusive, Dr Andrew Rut, CEO of MyMeds&Me, discusses the value of big data for the pharma industry and the conflict that arises between protecting personal data and effective drug development more
Key European process patent granted to Evgen Pharma
Clinical-stage drug development company, Evgen Pharma, has been granted a key European patent ascribing intellectual property rights to the company for a method of stabilising sulforaphane, which is the basis of its lead product, SFX-01 more
STA Pharmaceuticals to build new R&D centre in Shanghai
STA Pharmaceuticals (a subsidiary of WuXi AppTec) has signed an investment agreement with the government of Shanghai, Jinshan District to build a new R&D centre, aimed at strengthening the company’s pharma development and manufacturing platform. more
Catalent to invest $5 million to create new drug development centre of excellence
Catalent Pharma Solutions has revealed its plans to invest $5 million in the creation of a new drug development centre of excellence (CoE) at its Somerset, New Jersey facility and headquarters more
New ‘tech’ on the block: The critical role of new tech in advancing patient autonomy and drug development
Dr Andrew Rut, CEO and founder of MyMeds&Me, examines the critical role of new technology, in the form of smart pharmaceuticals and blockchain, in advancing patient autonomy and drug development. more
French connection: NDA Group opens Parisian office
NDA Group, European drug development consultancy, has opened a new office in Paris, France, to serve its growing customer base in the country and continue its global expansion. more
Attitude toward safety in cancer drug development needs to change, says ApconiX co-founder
A co-founder of the company ApconiX, based in Alderley Park, has revealed his view that attitude towards safety in pre-clinical cancer drug development needs to change. more
New homes for old drugs: Could repurposing offer a financial solution?
Health systems are facing the biggest challenge in their existence: financial sustainability fuelled by the costs of prescription drugs. Here, Marisa Miraldo, associate professor at Imperial College Business School, goes into more detail… more
Evgen Pharma and King’s collaborate to advance therapy for ischaemic stroke
Evgen Pharma, a clinical-stage drug development company, has announced its collaboration with King’s College London to advance its lead product candidate as a therapy for ischaemic stroke. more
ApconiX sees sales boost as demand for drug safety expertise increases
A nonclinical safety company that works with the pharma sector based in Alderley Park, ApconiX, has increased sales by five-fold as a result of the industry’s demand for drug safety expertise. more
